ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Ryman Healthcare Ltd (PK)

Ryman Healthcare Ltd (PK) (RYHTY)

12.05
0.00
(0.00%)
Closed January 13 3:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
12.05
Bid
11.19
Ask
14.00
Volume
26
0.00 Day's Range 0.00
10.66 52 Week Range 18.12
Previous Close
12.05
Open
-
Last Trade
26
@
11.659
Last Trade Time
Average Volume (3m)
1,160
Financial Volume
-
VWAP
-

RYHTY Latest News

Ex-Dividend

Mon, Jun 03, 2013 08:00 - Ryman Healthcare Ltd. (RYHTY: Grey Market) - Ex-Dividend - As of Tue, Jun 04, 2013, Ryman Healthcare Ltd. traded ex-dividend. Ryman Healthcare Ltd. will disburse a Cash...

Scheduled Ex-Dividend

Wed, May 22, 2013 08:00 - Ryman Healthcare Ltd. (RYHTY: Grey Market) - Scheduled Ex-Dividend - Ryman Healthcare Ltd. has announced a dividend ex-date for (RYHTY: Grey Market). Ryman Healthcare...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10012.0512.0512.0511212.05DR
4-0.52-4.1368337311112.571312112312.74976247DR
12-2.45-16.896551724114.514.812116013.29972287DR
26-1.55-11.397058823513.616.5712100113.92017256DR
52-6.07-33.498896247218.1218.1210.66118713.72047328DR
156-25.55-67.952127659637.637.610.66108117.90864982DR
260-39.46-76.606484177851.5158.5810.6690024.63012736DR

RYHTY - Frequently Asked Questions (FAQ)

What is the current Ryman Healthcare (PK) share price?
The current share price of Ryman Healthcare (PK) is US$ 12.05
What is the 1 year trading range for Ryman Healthcare (PK) share price?
Ryman Healthcare (PK) has traded in the range of US$ 10.66 to US$ 18.12 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CRGPCalissio Resources Group Inc (CE)
US$ 0.0004
(39,900.00%)
20k
SMMESmartMetric Inc (PK)
US$ 0.0001
(9,900.00%)
1.25M
NEOMNeoMedia Technologies Inc (CE)
US$ 0.0001
(9,900.00%)
534.97k
RRGIReality Racing Inc (CE)
US$ 0.0001
(9,900.00%)
209k
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.0001
(9,900.00%)
290
IBKKFImining Technologies Inc (CE)
US$ 0.000001
(-100.00%)
100
EGIOQEdgio Inc (CE)
US$ 0.000001
(-99.99%)
905
CYBFCyberfort Software Inc (CE)
US$ 0.000001
(-99.88%)
20k
CHMJDWaverunner Capital Inc
 0.0045
(-99.40%)
106
CCTLCoin Citadel (PK)
US$ 0.000001
(-99.00%)
108k
HMBLHUMBL Inc (PK)
US$ 0.0009
(0.00%)
359.72M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.00015
(50.00%)
194.9M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.00375
(-1.32%)
188.36M
TSOITherapeutic Solutions International Inc (PK)
US$ 0.0002
(-33.33%)
168.26M
PHILPHI Group Inc (PK)
US$ 0.00025
(-16.67%)
129.87M

Discussion

View Full Feed
Wayne R Wayne R 13 minutes ago
It's a fashion statement and ecologically friendly
Investor2014 Investor2014 17 minutes ago
Whether you like it or not, it is a fact that in May 120 days will have passed since the CHMP accepted the Anavex MAA. That will be clock stop one in the EMA process, where it is highly unlikely there will no questions raised for Anavex to reply to and for which 90 days are available.

AVXL
ducci1 ducci1 19 minutes ago
Pivot Calcs: SPX Pivot--5841----R1--5875----R2--5924-----S1--5792----S2--5758----SPY Pivot--581----R1--584----S1--576-----Vix Pivot--19.30----R1--2055----R2--21.56----R3--23.82----S1--18.29 !!LOL!!
SPY
meshcan meshcan 20 minutes ago
Nobody forcing you to stay here unless you want and you most likely are benefiting from bashing Elite or shorting or day trading...otherwise what you are saying doesn't make sense.

I know many longs here are already millionaire with current price, ~0.5 pps, but I'm sure they are waiti
ELTP
along4zride along4zride 21 minutes ago
Get ready to be thrown under (FNMA) bus .
No way no how slick suit and haircut Wall Street huckster gives one cent care about hopeful investor. More than likely common share holder has been ginned up . Sheep ready for slaughter or should I say vultures .

FNMA
jxyzobrien jxyzobrien 28 minutes ago
tangerine Mussolini
Killing the market
layoffs all over
tariff news has not yet brought in long term sellers
market should be up sunday nite NOPE
Hi_Lo Hi_Lo 37 minutes ago
Lol!! I want profits!! What you want helps me in no way!!
Exactly. Because the truth with documentation that BCAP is a scam and Jake P. Noch is a serial scammer prevents scamming pumpers and liars like you from making profits by creating bagholders here. And that's part of my goal - and to h
BCAP
DiamondHealer95 DiamondHealer95 41 minutes ago
What do you expect and how can you back your thoughts? Thanks
KBLB
DiamondHealer95 DiamondHealer95 47 minutes ago
I mean Kim said once they hit 1.5 metric tons they're open for business and they're about halfway there so..... You're a genius! Congrats on the business. I also run one with 100% positive feedback over 22 years so I get the perspective🤪

Also, in my Arby's voice "I have the
KBLB
DiamondHealer95 DiamondHealer95 50 minutes ago
We've invested similarly
KBLB
sunspotter sunspotter 1 hour ago
Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
VPLM
Flobewan Flobewan 1 hour ago
Marc loved your ides
tinojax tinojax 1 hour ago
I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
PLUG
mrfence mrfence 1 hour ago
Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
[yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
FMCC FNMA
IVRT IVRT 2 hours ago
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 2 hours ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 2 hours ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

Guido2 Guido2 2 hours ago
This is DUE DILIGENCE! Thank you Free Fannie.

https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
StockItOut StockItOut 2 hours ago
That Xeriant PR excellently written with bullshit:

""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

"the Company used the data to make several key
XERI